Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

XLV vs. FACDX: which is better?

Bottom line

XLV vs FACDX: the short answer

XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) and FACDX (Fidelity Advisor Health Care Fund) share a meaningful slice of their top holdings — about 45% by weight.

But FACDX is far broader, holding 154 positions to 65 for XLV, so beyond the top names it adds exposure XLV doesn't have.

XLV is cheaper at 0.08% vs 0.96% — a difference of $88 a year per $10,000 invested.

Over five years, XLV returned +8.1% a year vs +2.3% for FACDX (reporting dates differ).

Updated Nov 19, 2026

XLV vs FACDX side by side

XLVFACDX
TypeETFMutual fund
Fund familySPDR (State Street)Fidelity
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.08%0.96%
Annual cost per $10k$8$96
10-yr cost on $10k (prospectus)$103$1,685
Max front loadNone—
12b-1 fee0.02%0.25%
1-yr return+14.5%+7.7%
5-yr return (annualized)+8.1%+2.3%
10-yr return (annualized)+9.8%+7.6%
Best quarter+14.5%+21.3%
Worst quarter−12.7%−15.0%
Net assets (fund)$40.6B$3.1B
Number of holdings65154
Portfolio turnover2%74%
Returns as ofDec 31, 2025Sep 30, 2026

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearXLVFACDXDifference
2025+14.5%+14.2%+0.3%
2024+2.5%+3.9%−1.4%
2023+2.0%+3.8%−1.8%
2022−2.1%−13.1%+11.0%
2021+25.9%+11.2%+14.7%
2020+13.3%+21.1%−7.8%
2019+20.7%+27.9%−7.2%
2018+6.3%+7.3%−1.1%
2017+21.7%+24.1%−2.4%
2016−2.8%−10.3%+7.5%

Source: Fund prospectus bar charts

Holdings overlap

10 of XLV's top 25 holdings also appear in FACDX's top 25.

Shared top holdings
HoldingXLVFACDX
Eli Lilly & Co16.51%7.66%
Johnson & Johnson10.64%3.78%
AbbVie Inc7.74%3.62%
UnitedHealth Group Inc6.57%4.17%
Merck & Co Inc5.52%2.09%
Thermo Fisher Scientific Inc3.24%6.31%
Gilead Sciences Inc2.73%1.25%
CVS Health Corp2.30%1.29%
Danaher Corp2.09%6.75%
Boston Scientific Corp1.10%1.23%

Source: SEC Form N-PORT

XLV top 10

  1. Eli Lilly & Co — 16.51%
  2. Johnson & Johnson — 10.64%
  3. AbbVie Inc — 7.74%
  4. UnitedHealth Group Inc — 6.57%
  5. Merck & Co Inc — 5.52%
  6. Amgen Inc — 3.40%
  7. Thermo Fisher Scientific Inc — 3.24%
  8. Abbott Laboratories — 2.75%
  9. Gilead Sciences Inc — 2.73%
  10. Intuitive Surgical Inc — 2.45%

FACDX top 10

  1. ELI LILLY and CO — 7.66%
  2. Danaher Corp — 6.75%
  3. Thermo Fisher Scientific Inc — 6.31%
  4. Unitedhealth Group Inc — 4.17%
  5. JOHNSON and JOHNSON — 3.78%
  6. Abbvie Inc — 3.62%
  7. Fidelity Revere Street Trust — 2.54%
  8. Argenx Se — 2.09%
  9. MERCK and CO INC — 2.09%
  10. West Pharmaceutical Svcs Inc — 2.06%

FAQ

What is the difference between XLV and FACDX?
XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) and FACDX (Fidelity Advisor Health Care Fund) share a meaningful slice of their top holdings — about 45% by weight. But FACDX is far broader, holding 154 positions to 65 for XLV, so beyond the top names it adds exposure XLV doesn't have.
Which is cheaper, XLV or FACDX?
XLV has the lower expense ratio (0.08%).
Should I own both XLV and FACDX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.